Sign in to fuzzto save your conversations, follow your research and come back anytime.
Apollo Hospitals
SectorHealthcare
Apollo Hospitals Enterprise Limited (AHEL) is a leading private healthcare provider in Asia. It operates a network of hospitals, pharmacies, primary care clinics, and diagnostic centers. As of March 31, 2023, AHEL had a capacity of 9,957 beds across 70 hospitals in India and overseas. This includes 8,544 beds in 43 owned hospitals, 305 beds in 11 cradles, 257 beds in 11 day care/short surgical stay centers, and 851 beds in 5 hospitals operated through management contracts. The company has expanded through acquisitions, joint ventures, and new facility launches. AHEL has also diversified into health insurance, retail pharmacy, and digital healthcare platforms. The company has undergone various corporate restructurings to optimize its business operations across different healthcare segments.
In the news
SC questions drug price caps beyond cancer medicines, pharma stocks fall
Hospital stocks face 2-9% EBITDA hit as SC flags ₹27,000 cancer drug markup
Apollo Hospitals Eyes 100 BPS Cost Cut, Opposes Price Caps
Trade Spotlight: 34 stocks for September 25 with updated brokerage targets
Apollo Hospitals, Torrent Pharma Get Strong Buy Recommendations
Private hospitals add 34,000 beds but meet only 1.4% of demand
Apollo Hospitals, Max Healthcare Eye India's 100K Bed Shortage
Trading Ideas: 15 Stocks for August 17 with Technical Setups
Hospital Sector Shows Strong Q1 Growth Despite Capacity Expansion Challenges
Top 10 stocks rated 'Buy' offer 11-42% upside potential
Nifty hits 5-month high at 23,774; Apollo Hospitals gains 0.54%
Zydus-Apollo Shield MCD Partnership: India's Cancer Screening Revolution
Top 10 stocks rated 'Buy' show 17-48% upside potential
Max Healthcare Gets 'Hold' Rating Despite 4,000 Bed Expansion Plans
Apollo Hospitals' ₹17.76 Crore FEMA Settlement: What It Means
Healthcare stocks surge 27% in FY27, analysts see 17% upside potential
Market correction nearing end; pharma, banking bets advised
Apollo Hospitals Expands Network to 13,100 Beds
Morgan Stanley Raises Timken Target to $140, Maintains Bullish Views
Top stocks to BUY, SELL or HOLD Today: ITC, Page Industries, JSW Cement
The Quarter story
The two most recent quarterly results, compared side-by-side.
Apollo Hospitals shows strong profitability and network expansion, though recent revenue and volume dips point to partial quarter reporting.
Hospital EBIT grew from ₹5,610 Cr to ₹6,820 Cr from Q1 FY26 to Q1 FY27, demonstrating consistent profitability
Consolidated revenue fell from ₹29,351 Cr to ₹11,395 Cr from Q1 FY26 to Q1 FY27, suggesting seasonal or reporting variance
EBITDA margin expanded from 9.3% to 24.2% from Q1 FY26 to Q1 FY27, signaling strong cost control
Inpatient volume dropped from 151,558 to 15,370 from Q1 FY26 to Q1 FY27, likely reflecting a partial quarter report
Diagnostics footfalls per day rose from 20,820 to 24,778 from Q1 FY26 to Q1 FY27, indicating strong test demand
Pharmacy store count grew from 6,742 to 7,440 from Q1 FY26 to Q1 FY27, expanding the retail footprint
Hospital occupancy rate climbed from 65% to 70% from Q1 FY26 to Q1 FY27, reflecting improved bed utilization
Company insights, generated from the most recent coverage.
Digital cash losses narrowed 80% YoY while pharmacy and diagnostics are compounding at 25-30%+ — the loss-making digital arm is no longer a drag on the sum-of-the-parts story.
RSI at 20.41 and Stochastic at 7.83 are at extreme oversold readings — historically these levels precede a short-term technical bounce even inside a strong downtrend.
Down 1.97% to ₹7,828 on Oct 6 on just 0.23x of 1-month average volume — no panic selling, but zero buying support to arrest the slide.